Podcast Q&A: Improving the Representativeness of Research
This podcast segment features the Q&A from Cardinal Health's March 23, 2023 webinar with HealthEconomics.Com. Join Dr. Bruce Feinberg, Dr. [...]
Podcast Q&A: Advancing Patient Care through Real-World Data, Machine Learning, and Systems Biology
This podcast segment from Syapse's September 21, 2022 webinar features the Q&A with Nitin Baliga, Insitute of Systems Biology, and [...]
On-Demand Webinar: Navigating the Path to the Clinic And Beyond For Gene Therapies
Bringing novel gene therapies from the drawing board to patients requires careful consideration of each step of the pipeline. A [...]
Free eBook: Revisiting Rare Disease
Rare Disease Advisor is now offering a free eBook that shines a light on the state of the rare disease [...]
Cytel Blog Discusses Whether Promising Zone Design is Optimal
Jennison and Turnbull developed promising zone design in 2015 to help determine initial sample sizes for early clinical trials that [...]
Clinical Research News Podcast Discusses Solara and LiveSLR
The impact of Cytel’s Solara and LiveSLR technologies on the relationship between forecasting and evidence technology is examined on the [...]
Germany’s Digital Healthcare Act and Real-World Evidence
Germany's 2019 Act to Improve Healthcare Provision through Digitization and Innovation has accelerated the implementation of digital health applications (DiGa). [...]
Webinar on RWE and Progress During COVID-19 Pandemic
The COVID-19 Pandemic has driven many researchers to incorporate RWE (real world evidence) into clinical trials. However, it can often [...]
The Positive Impact of COVID-19 on Clinical Trials
Although COVID-19 has resulted in many negative consequences, it has also brought about some useful changes in the drug development [...]
Growing Support for HTA in Light of High Gene Therapy Costs
An independent review board, such as ICER, responsible for assessing appropriate costs for therapies and drugs has been discussed for [...]
COVID-19 News: Eli Lilly Drug Receives FDA Emergency Authorization; Drug Pricing Language in COVID-19 Bill
Two recent developments related to COVID-19 are a new drug approval and a relief bill containing a drug pricing proposal. [...]
Read Up On How Regulators Are Using RWE
RWE is playing a growing role in FDA approvals. According to an Aetion analysis, 49 percent of submissions for new drugs [...]
Delays in Clinical Trials Present Pharma Companies With Opportunities to Evolve
COVID-19 has upended clinical trial timelines – putting billions of forecasted sales at risk and delaying getting life-saving treatments to [...]
Pathways for Regulatory and HTA of Histology Independent Therapies
Histology independent therapies represent a new era in personalized healthcare and drug development while challenging existing diagnostic and value assessment [...]
Minimizing Risk & Accelerating Timelines in Oncology Trials
Cancer has an etiology that involves a wide range of genetic interactions and dysfunction across multiple systems. These characteristics make [...]
Advanced Design Framework with Yannis Jemiai
The clinical trial design process has been irrevocably altered by cloud-based computing. Until recently, it would take a statistician a [...]
The Value of Detailed Clinical Trial Simulations for Rare Diseases
In this latest blog, Cytel statistician Ursula Garczarek discusses the contentious topic of measuring treatment effect during rare disease trials [...]
The Disturbing Dearth of Evidence for Supportive Oncology
Despite historical reliance on evidence generated from randomized controlled trials (RCTs), there has been a surge in the number of [...]
Trial Site Networks: Create Positive Change Through A Shift in Perspective
COVID-19 represents a stress test of sorts for our global healthcare system that will hopefully lead to positive changes over [...]
Adaptive Trial Designs in Early Oncology
Our understanding of the genetic and molecular mechanisms that lead to cancer have improved greatly over the past decade thanks [...]
Ethnoracial Disparities Pervasive in Clinical Research
As clinical trials are the gold standard for evidence-based medicine, it is essential for researchers to be as inclusive as [...]
Enhancing RWE through Natural History Studies
Deploying RWE-analyses is not just a simple matter of having sufficient statistical knowledge. There are a variety of RWE methodologies [...]
[Webinar] How Can Adaptive Designs and Master Protocols Enhance Your Oncology Trials?
While oncology trials comprise a large proportion of current research pipelines, conventional oncology development programs are frequently expensive, inefficient, and [...]
How to Excel at Next Generation Trial Execution
The coming generation of clinical trials will be quicker, more efficient, and result in better patient outcomes. As the COVID-19 [...]
Cytel Releases Audiobook on Synthetic Control Arms (SCA)
Synthetic control arms (SCA) are virtual trial arms using observational data and historical claims data to simulate a study’s control [...]